Evidence map›Paper›PMID 39441352›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.

Nagarajan Raju, Kevin J Kramer, Mattia Cavallaro, Roberta A Diotti, Andrea R Shiakolas, Yailin Campos Mota, Robert A Richardson, Ileia J Scheibe, Ted M Ross, Ivelin S Georgiev and 1 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nagarajan RajuVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-3851-5520
Kevin J KramerVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN.
Mattia CavallaroUniversità Vita-Salute San Raffaele, Milan, Italy.
Roberta A DiottiPomona Ricerca S.r.l., Turin, Italy.ORCID 0000-0002-7853-3224
Andrea R ShiakolasVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-9391-5434
Yailin Campos MotaFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL.
Robert A RichardsonFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL.ORCID 0000-0003-3702-8122
Ileia J ScheibeCenter for Vaccines and Immunology, University of Georgia, Athens, GA.ORCID 0000-0002-9374-7407
Ted M RossFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL.
Ivelin S GeorgievVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN.
Giuseppe A SauttoFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL.ORCID 0000-0002-0273-2235

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor SequenceR01AI175245 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ivelin Georgiev · 2023 to 2026
$3.4M
NIAID NIH HHS 75N93019C00052NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI175245NIH HHS HHSN272201400008CUniversity of Georgia (UGA) UGA-001Vanderbilt Institute for Clinical and Translational Research (VICTR)
6 · The paper itself

Abstract

Influenza virus is a highly contagious respiratory pathogen causing between 9.4 and 41 million infections per year in the United States in the last decade. Annual vaccination is recommended by the World Health Organization, with the goal to reduce influenza severity and transmission. Ag-specific single B cell sequencing methodologies have opened up new avenues into the dissection of the Ab response to influenza virus. The improvement of these methodologies is pivotal to reduce the associated costs and optimize the operational workflow and throughput, especially in the context of multiple samples. In this study, PBMCs and serum samples were collected longitudinally from eight influenza vaccinees either vaccinated yearly for four consecutive influenza seasons or once for one season. Following the serological and B cell profiling of their polyclonal Ab response to a panel of historical, recent, and next-generation influenza vaccine hemagglutinin (HA) and virus strains, a single multiplexed Ag-specific single B cell sequencing run allowed to capture HA-specific memory B cells that were analyzed for preferential Ig H chain/L chain pairing, isotype/subclass usage, and the presence of public BCR clonotypes across participants. Binding and functional profiles of representative private and public clonotypes confirmed their HA specificity, and their overall binding and functional activity were consistent with those observed at the polyclonal level. Collectively, this high-resolution and multiplexed Ab repertoire analysis demonstrated the validity of this optimized methodology in capturing Ag-specific BCR clonotypes, even in the context of a rare B cell population, such as in the case of the peripheral Ag-specific memory B cells.

Indexed as

Antibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza, HumanInfluenza VaccinesMemory B CellsAdultFemaleHumansImmunologic MemoryMaleMiddle AgedVaccinationAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza Vaccines

Identifiers

PMID39441352
PMCPMC11573632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.